收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction Kita Y., Ito K., Kanda S....
2 Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study Klein E.A., Partin A., Lotan Y....
3 Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma Li X., Li H., Gao X.-S....
4 Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients You S., Kim M., Widen S....
5 A new catheter-integrated drug-delivery system for controlled intravesical mitomycin C release Staerk K., Hjelmager J.S., Alm M....
6 The clinical value of circulating free tumor DNA in testicular germ cell tumor patients Kramarzova K.S., Zwyrtkova M., Bakardjieva-Mihaylova V....
7 Immune checkpoints inhibitors in the management of high-risk non-muscle-invasive bladder cancer. A scoping review Garcia-Perdomo H.A., Sanchez A.L., Spiess P.E.
8 Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma Colla Ruvolo C., Deuker M., Wenzel M....
9 Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer Lokeshwar S.D., Nguyen J., Rahman S.N....
10 Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle–invasive bladder cancer Tong S., Hu X., Li Y.